It's more nuanced than that. For instance, Chinese dumping caused many renewable companies in Europe to go bankrupt, which possibly slowed down innovation. I won't pretend to know the details of either, but often it happens that consolidation yields undesired consequences.

Not OP, but with them about it being "not hard" compared to the current horrific handling of the situation in China: it's costly (economically, socially, psychologically, …) and inefficient (current variants put us past the point where lockdowns would suffice to stop the spread, and every week that goes gives a new evidence of it).

> "For the first time, a majority of Americans dying from the coronavirus received at least the primary series of the vaccine.

Could you explain what it is that you find controversial about it? That's not a measure of vaccines efficiency, it is merely a measure of their intake.